000			05191nam a22004095i 4500
999			_c122001 _d122001 _x1
001			122001
003			ES-MaUEC
005			20230102114158.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			200731s2020 si a o |||| 0|eng d
020			_a9789811522130
024	7		_a10.1007/978-981-15-2213-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRE350 _b2020 EB
245	0	0	_aChoroidal Neovascularization _cedited by Jay Chhablani
250			_aFirst edition
264		1	_aSingapore _bSpringer International Publishing _c2020
300			_a1 recurso en línea (XVII, 433 páginas) _b171 ilustraciones, 159 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
490	0		_aMedicine (SpringerNature-11650)
490	0		_aMedicine (R0) (SpringerNature-43714)
505	0		_aSection I: History -- History of choroidal neovascularization (CNV) - initial understanding and development -- Section II: Basics -- Pathogenesis - various proposed mechanisms -- Histopathology - recent understanding in relationship with imaging -- Electron microscopy - update in choroidal changes -- Section III: Clinical classification -- Neovascular age-related macular degeneration (AMD) - clinical features, imaging, protocols and outcomes -- CNV secondary to pathologic myopia - clinical features, imaging and treatment outcomes -- Pachychoroid related CNV - recent updates, imaging and outcomes -- Inflammatory CNV - clinical features, imaging and treatment outcomes -- Dystrophy related CNV - clinical features, imaging and treatment outcomes -- CNV secondary to angioid streaks - clinical features, imaging and treatment protocols -- Idiopathic CNV - clinical features, imaging and treatment outcomes -- CNV associated with idiopathic juxtafoveal telangiectasia - clinical features, imaging and treatment outcomes -- CNV associated with other causes - laser induced, idiopathic intracranial hypertension, choroidal osteoma, trauma, choroidal coloboma, choroidal nevus, etc -- Peripapillary CNVM - overview of various causes, imaging features and treatment outcomes -- Pediatric CNVM - overview of various causes, imaging features and treatment outcomes -- Polypoidal choroidal vasculopathy (PCV) - clinical features, imaging and treatment outcomes -- Section IV: Treatment options -- Anti-VEGF current options - Ranibizumab, Bevacizumab, Aflibercept, Ziv-aflibercept, Conbercept -- Photodynamic therapy - current status in anti-VEGF era -- Surgical intervention - graft, retinal implant, the implantable miniature telescope, surgical removal of CNV, subretinal tissue plasminogen activator -- Section V: Clinical trials -- n-AMD trials - comprehensive overview of PDT and anti-VEGF trials in AMD -- Myopic CNV trials - comprehensive overview of PDT and anti-VEGF trials in AMD -- Non-AMD CNV trials - comprehensive overview of various trials in non-AMD related CNV causes -- PCV trials - comprehensive overview of PDT and anti-VEGF trials in PCV -- Section VI: Future directions -- Stem cells in AMD - current status and future expectations -- Newer molecules - newer targets in CNV and the upcoming research -- Radiotherapy - role of radiotherapy and clinical trials -- Other options - role of subthreshold laser, and other therapies in CNV -- Section VII: Rehabilitation -- Low vision aids -- Peripheral vision development - newer approach for macular diseases -- Monitoring techniques - advanced home monitoring techniques and initial experience.
520			_aThe book discusses all aspects of choroidal neovascularization (CNV), including the basics, clinical conditions associated with CNV, clinical trials related to CNV, future directions and rehabilitation. The first section covers the pathogenesis, proposed mechanisms, disease models, histopathology and electronmicroscopy. The next section explores CNV secondary to various clinical conditions, such as age-related macular degeneration (AMD), myopia, and less common conditions like choroidal osteoma. The book also covers clinical features, imaging characteristics, and treatment approaches, as well as clinical trials in CNV conditions with recent updates. Lastly, it features chapters on stem cell therapy, gene therapy, new molecules, and lasers, as well as a section on rehabilitation, which addresses home monitoring and low vision aids. This book is intended for retina specialists, retina fellows and general ophthalmologists.
988			_aSpringer_Medicine_2020
650		7	_2embne _aOjos _xEnfermedades _9168866
700	1		_aChhablani, Jay _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _1http://viaf.org/viaf/168150264365005860008
776	0	8	_iPrinted edition: _z9789811522123
776	0	8	_iPrinted edition: _z9789811522147
776	0	8	_iPrinted edition: _z9789811522154
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-2213-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b09/2020 _dz _ea _zSI